Media coverage
1
Media coverage
Title Icahn School of Medicine at Mount Sinai Listed a New Clinical Trial to Study of Iberdomide (CC-220) in Combination With Elotuzumab and Dexamethasone for Relapsed/Refractory Multiple Myeloma (CC-220) Media name/outlet India Pharma News Country/Territory India Date 29/09/22 URL metabase.moreover.com/noarticleurl?type=psh&lni=66HD-RCP1-JB5M-W1GH-00000-00 Persons Samir Parekh